Paolo Fusar-Poli1. 1. Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.
Abstract
BACKGROUND: Reliable neurofunctional markers of increased vulnerability to psychosis are needed to improve the predictive value of psychosis risk syndrome and inform preventive interventions. METHODS: I performed a signed differential mapping (SDM) voxel-wise meta-analysis of functional magnetic resonance imaging (fMRI) studies of patients at clinical high risk for psychosis. RESULTS: Ten studies were included in the analysis. Compared with controls, high-risk patients showed reduced neural activation in the left inferior frontal gyrus (Brodmann area [BA] 9) and in a cluster spanning the bilateral medial frontal gyrus (BA 8,6), bilateral superior frontal gyrus (BA 8,6)and the left anterior cingulate (BA 32). There was no publication bias. Heterogeneity across studies was low. Sensitivity analysis confirmed the robustness of the findings. LIMITATIONS: The cross-sectional nature of the included studies prevented the comparison of high-risk patients who later experienced a psychotic episode with those who did not. Other caveats are reflected in methodologic heterogeneity across tasks employed by different individual imaging studies. CONCLUSION: Reduced neurofunctional activation in prefrontal regions may represent a neurophysiologic correlate of increased vulnerability to psychosis.
BACKGROUND: Reliable neurofunctional markers of increased vulnerability to psychosis are needed to improve the predictive value of psychosis risk syndrome and inform preventive interventions. METHODS: I performed a signed differential mapping (SDM) voxel-wise meta-analysis of functional magnetic resonance imaging (fMRI) studies of patients at clinical high risk for psychosis. RESULTS: Ten studies were included in the analysis. Compared with controls, high-risk patients showed reduced neural activation in the left inferior frontal gyrus (Brodmann area [BA] 9) and in a cluster spanning the bilateral medial frontal gyrus (BA 8,6), bilateral superior frontal gyrus (BA 8,6)and the left anterior cingulate (BA 32). There was no publication bias. Heterogeneity across studies was low. Sensitivity analysis confirmed the robustness of the findings. LIMITATIONS: The cross-sectional nature of the included studies prevented the comparison of high-risk patients who later experienced a psychotic episode with those who did not. Other caveats are reflected in methodologic heterogeneity across tasks employed by different individual imaging studies. CONCLUSION: Reduced neurofunctional activation in prefrontal regions may represent a neurophysiologic correlate of increased vulnerability to psychosis.
Authors: P Fusar-Poli; S Bhattacharyya; P Allen; J A Crippa; S Borgwardt; R Martin-Santos; M Seal; C O'Carroll; Z Atakan; A W Zuardi; P McGuire Journal: J Clin Neurosci Date: 2010-01-15 Impact factor: 1.961
Authors: R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt Journal: Neurosci Biobehav Rev Date: 2010-02-06 Impact factor: 8.989
Authors: Paolo Fusar-Poli; Oliver D Howes; Paul Allen; Matthew Broome; Isabel Valli; Marie-Claude Asselin; Paul M Grasby; Philip K McGuire Journal: Arch Gen Psychiatry Date: 2010-07
Authors: Katharina Pauly; Nina Y Seiferth; Thilo Kellermann; Stephan Ruhrmann; Bianca Daumann; Volker Backes; Joachim Klosterkötter; N Jon Shah; Frank Schneider; Tilo T Kircher; Ute Habel Journal: Schizophr Res Date: 2010-01-06 Impact factor: 4.939
Authors: Paolo Fusar-Poli; Anna Placentino; Francesco Carletti; Paola Landi; Paul Allen; Simon Surguladze; Francesco Benedetti; Marta Abbamonte; Roberto Gasparotti; Francesco Barale; Jorge Perez; Philip McGuire; Pierluigi Politi Journal: J Psychiatry Neurosci Date: 2009-11 Impact factor: 6.186
Authors: Fred W Sabb; Theo G M van Erp; Molly E Hardt; Mirella Dapretto; Rochelle Caplan; Tyrone D Cannon; Carrie E Bearden Journal: Schizophr Res Date: 2009-10-27 Impact factor: 4.939
Authors: Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey Journal: Neuropsychopharmacology Date: 2009-08-12 Impact factor: 7.853
Authors: Maria Jalbrzikowski; David Freedman; Catherine E Hegarty; Eva Mennigen; Katherine H Karlsgodt; Loes M Olde Loohuis; Roel A Ophoff; Raquel E Gur; Carrie E Bearden Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-01-18 Impact factor: 8.829
Authors: Heidi W Thermenos; Richard J Juelich; Samantha R DiChiara; Raquelle I Mesholam-Gately; Kristen A Woodberry; Joanne Wojcik; Nikos Makris; Matcheri S Keshavan; Susan Whitfield-Gabrieli; Tsung-Ung W Woo; Tracey L Petryshen; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman Journal: Schizophr Res Date: 2016-03-07 Impact factor: 4.939
Authors: Daniel H Wolf; Theodore D Satterthwaite; Monica E Calkins; Kosha Ruparel; Mark A Elliott; Ryan D Hopson; Chad T Jackson; Karthik Prabhakaran; Warren B Bilker; Hakon Hakonarson; Ruben C Gur; Raquel E Gur Journal: JAMA Psychiatry Date: 2015-05 Impact factor: 21.596
Authors: Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548
Authors: Nikolaos Koutsouleris; Anita Riecher-Rössler; Eva M Meisenzahl; Renata Smieskova; Erich Studerus; Lana Kambeitz-Ilankovic; Sebastian von Saldern; Carlos Cabral; Maximilian Reiser; Peter Falkai; Stefan Borgwardt Journal: Schizophr Bull Date: 2014-06-09 Impact factor: 9.306
Authors: Michael S Rafii; Curtis S Taylor; Hyun T Kim; Rahul S Desikan; Adam S Fleisher; David Katibian; James B Brewer; Anders M Dale; Paul S Aisen Journal: Am J Alzheimers Dis Other Demen Date: 2013-10-27 Impact factor: 2.035